Prolongation and quality of life for HIV-infected adults treated with highly active antiretroviral therapy (HAART): a balancing act.

@article{Burgoyne2008ProlongationAQ,
  title={Prolongation and quality of life for HIV-infected adults treated with highly active antiretroviral therapy (HAART): a balancing act.},
  author={Robert W. Burgoyne and Darrell H. S. Tan},
  journal={The Journal of antimicrobial chemotherapy},
  year={2008},
  volume={61 3},
  pages={469-73}
}
Advances in highly active antiretroviral therapy (HAART) options for people living with HIV/AIDS have resulted in decreased morbidity and mortality. To some extent, the role of disease progression in eroding quality of life (QOL) erosion in the pre-HAART age is now supplanted by drug toxicities, one of the Achilles' heels of HAART. This article reviews research findings on treatment and QOL outcomes a decade into the HAART era. 

Citations

Publications citing this paper.
Showing 1-10 of 42 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 64 references

TMC114/r is well tolerated by treatment-experienced patients in POWER 1, 2 and 3: integrated clinical safety analysis

  • J Valdez Madruga, A Lafeuillade, G Beatty
  • XVI International AIDS Conference,
  • 2006
1 Excerpt

on the Global AIDS Epidemic 2006

  • UNAIDS. Repor
  • Geneva: UNAIDS,
  • 2006
1 Excerpt

Similar Papers

Loading similar papers…